Childhood cancers: open trials in Spain

153 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-11-06
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Micancer Center S.L.P., Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-06
NCT05533775
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid
Registry updated 2026-11-05
NCT07223021
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Memorial Sloan Kettering Cancer Center
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-11-05
2023-504264-41-00
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · F. Hoffmann-La Roche AG
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid
Registry updated 2026-11-04
NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron (Site 1100), Barcelona · MD Anderson Cancer Center-Oncology (Site 1102), Madrid · Hospital Universitario 12 de Octubre-Medical Oncology (Site 1103), Madrid · Hospital Universitario Central de Asturias-Medical Oncology (Site 1101), Oviedo
Registry updated 2026-11-03
NCT06323447
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Research · Leuko Labs, Inc.
Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-03
NCT07328425
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Trial Treatment · Phase 2 · Italian Sarcoma Group
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Clínico San Carlos, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Miguel Servet, Zaragoza · HOSPITAL CLINICO UNIVERSITARIO VIRGEN DE LA ARRIXACA
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario Ramón y Cajal, Madrid · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Hospital Son Espases, Palma · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-02
NCT07888322
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Research · Aristotle University Of Thessaloniki
Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-02
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Clinica Universidad de Navarra, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-30
NCT07630974
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid
Registry updated 2026-10-30
NCT07700758
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-30
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
Research · EMD Serono Research & Development Institute, Inc.
Clinica Tres Torres, Barcelona · Institut Universitari Dexeus-Quiron - Servei d oncologia medica - Institut Oncologic Dr. Rosell, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Centro Oncologico MD Anderson, Madrid · Centro Integral Oncológico Clara Campa, Madrid · Hospital Regional Universitario de Malaga - Hospital General, Málaga · Hospidal Universitario Ntra. Sra. De Valme, Seville · Hospital Universitario Virgen Macarena, Seville · Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Registry updated 2026-10-29
NCT04855656
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1 · Debiopharm International SA
Hospital HM Nou Delfos, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Fundacion Rioja Salud, Logrono · Clinica Universidad de Navarra, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-28
NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Trial Treatment · Phase 1 · ITM Solucin GmbH
Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid
Registry updated 2026-10-27
NCT06459024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Research · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
University Hospital La Fe, Valencia
Registry updated 2026-10-27
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · University Hospital Son Espases, Palma · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-26
NCT07871864
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Hospital Universitario Cruces, Barakaldo · Vall d'Hebron Institute of Oncology (VHIO), Barcelona · Hospital Universitario del Niño Jesús, Madrid · Hospital General Universitario Gregorio Marañón, Pediatric and adolescent onco-haematology unit, Madrid · Hospital Virgen de la Arrixaca, Murcia · Hospital Universitario de Canarias, Santa Cruz de Tenerife · Hospital Universitario Virgen del Rocio, Seville · Hospital Universitari i Politécnic La Fe, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-26
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-21
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Hospital Universitario Principe de Asturias, Alcalá de Henares · Hospital General Universitario Dr. Balmis, Alicante · Institut Catala d'Oncologia, Badalona · Hospital del Mar, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario Virgen de las Nieves, Granada · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Central De Asturias, Oviedo · University Hospital Son Espases, Palma · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitari Joan XXIII de Tarragona, Tarragona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-21
NCT03394365
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Trial Treatment · Phase 3 · Pierre Fabre Medicament
Hospital Duran i Reynals (Adults and Pediatrics), Badalona · Hospital Universitari Vall d'Hebrón - Institut de Recerca (Adults and Pediatrics), Barcelona · Hospital General Universitario Gregorio Marañón (Adults and Pediatrics), Madrid · Hospital Universitario Marqués de Valdecilla (Adults and Pediatrics), Santander · University Hospital Virgen del Rocio (Adults and Pediatrics), Seville · Hospital Universitario La Fe (Adults and Pediatrics), Valencia
Registry updated 2026-10-19

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error